09/20/2022

Patient recruitment at the speed of science

Learn how Sermonix Pharmaceuticals partnered with Tempus and its TIME network of clinical sites to accelerate patient recruitment for a phase 2 study.
Authors Sibel Blau, MD
President and CEO, Quality Cancer Care Alliance Network
Medical Director, Northwest Medical Specialties




Matthew Cooney, MD
Vice President, Therapeutic Development, Tempus

Read the full article here